Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Front Immunol ; 12: 772239, 2021.
Article in English | MEDLINE | ID: mdl-34804064

ABSTRACT

This contribution explores in a new statistical perspective the antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 141 coronavirus disease 2019 (COVID-19) patients exhibiting a broad range of clinical manifestations. This cohort accurately reflects the characteristics of the first wave of the SARS-CoV-2 pandemic in Italy. We determined the IgM, IgA, and IgG levels towards SARS-CoV-2 S1, S2, and NP antigens, evaluating their neutralizing activity and relationship with clinical signatures. Moreover, we longitudinally followed 72 patients up to 9 months postsymptoms onset to study the persistence of the levels of antibodies. Our results showed that the majority of COVID-19 patients developed an early virus-specific antibody response. The magnitude and the neutralizing properties of the response were heterogeneous regardless of the severity of the disease. Antibody levels dropped over time, even though spike reactive IgG and IgA were still detectable up to 9 months. Early baseline antibody levels were key drivers of the subsequent antibody production and the long-lasting protection against SARS-CoV-2. Importantly, we identified anti-S1 IgA as a good surrogate marker to predict the clinical course of COVID-19. Characterizing the antibody response after SARS-CoV-2 infection is relevant for the early clinical management of patients as soon as they are diagnosed and for implementing the current vaccination strategies.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , COVID-19/blood , Immunoglobulin A/blood , SARS-CoV-2/immunology , Spike Glycoprotein, Coronavirus/immunology , Adult , Aged , Aged, 80 and over , COVID-19/immunology , Female , HEK293 Cells , Hospitalization , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Young Adult
2.
G Ital Med Lav Ergon ; 43(2): 99-110, 2021 Jun.
Article in Italian | MEDLINE | ID: mdl-34370919

ABSTRACT

SUMMARY: This paper describes how the health surveillance protocols adopted in hospitals and nursing homes have changed in response to the spread of SARS-CoV-2 and its risks. These changes concern assessments that must be performed with urgency, to detect potential cases and symptoms that may indicate contagion and to protect vulnerable and hypersensitive workers. Besides, these changes have been implemented in order to regulate how the appointed occupational physician should perform everyday tasks, particularly in regard to preventive visits, periodic visits, office visits, and visits meant to authorize one's return to the workplace. This paper recommends that both preventive visits and periodic visits should include rapid antigen swab tests to screen for SARS-CoV-2 (which, if positive, should be confirmed by molecular tests) and serologic tests to detect IgG SARS-CoV-2 antibodies. Since this phase involves great risks for healthcare facilities, this paper proposes that swab testing should be performed every month and that serologic testing should be performed every three months (depending on whether the first test detects the presence of IgG antibodies). By combining antigen and molecular swab tests, healthcare professionals can diagnose workers with SARS-CoV-2 and identify positive asymptomatic cases. Because of its costs and its long turnaround times for results, molecular swab testing is recommended only when one needs to confirm a positive antigen swab test result. Serologic testing should be used alongside swab testing, to acquire data concerning the immunity of workers.


Subject(s)
COVID-19 Serological Testing , COVID-19/diagnosis , Health Personnel , Occupational Health Services/organization & administration , Antibodies, Viral/blood , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Nucleic Acid Testing , Humans , Immunoglobulin G/blood , Return to Work , SARS-CoV-2/immunology , Symptom Assessment
3.
G Ital Med Lav Ergon ; 34(1): 7-15, 2012.
Article in Italian | MEDLINE | ID: mdl-22697024

ABSTRACT

This article describes in detail each stage of the shoe manufacturing process: design, cutting and shearing, sewing and trimming, assemblage, sole preparation, finishing, packaging and stocking, shoe manufacturing with synthetic materials. It will then discuss new technologies and their impact on the improvement of the worker's health, safety and convenience. A definition of the shoe parts and of the materials and machinery employed in its production will be provided, as well as a synthesis of the occupational hazards involved in each department. Although dealing with competitors who can take advantage of low-cost production and lack of concern for labour protection and environmental issues, the industry should always take great care of topics such as innovation and automation, but also workplace health and safety, while pushing the limits of that technological advance which companies have to face.


Subject(s)
Industry , Occupational Exposure , Shoes , Humans , Italy , Risk Assessment
4.
G Ital Med Lav Ergon ; 34(1): 37-42, 2012.
Article in Italian | MEDLINE | ID: mdl-22697030

ABSTRACT

In the present work the chemical compositions of the products used in shoes manufacturing are reported. The data were collected over the period 2004-2007 in 156 shoe factories in Vigevano area during a study aiming the evaluation of safety conditions and occupational exposure to hazardous chemicals of the employees. The study was part of a regional project for "Occupational cancer prevention in the footwear industry". In the first phase of the study an information form on production cycle, products used and their composition was filled during preliminary audit. In the second phase of the study an in depth qualitative/quantitative evaluation of professional exposure was conducted in 13 selected shoe factories. Data analysis showed the increase in use of water-based adhesives at expense of solvent-based adhesives, the reduction to less than 3.5 weight %, and up to 1 weight %, of n-hexane concentration in solvent mixtures, the increase in use of products containing less hazardous ketones, esters, cyclohexane and heptane. Only in very few cases, products containing from 4 to 12 weight% of toluene were used. These data attest a positive trend in workers risks prevention in shoes industry.


Subject(s)
Adhesives/adverse effects , Industry , Neoplasms/chemically induced , Neoplasms/prevention & control , Occupational Diseases/chemically induced , Occupational Diseases/prevention & control , Occupational Exposure/adverse effects , Occupational Exposure/prevention & control , Shoes , Solvents/adverse effects , Humans , Italy , Program Evaluation
SELECTION OF CITATIONS
SEARCH DETAIL
...